![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Greer I A. Haemostasis and thrombosis in pregnancy. Haemostasis and thrombosis, A L Bloom, C D Forbes, D P Thomas, E GD Tuddenham. Churchill Livingstone, Edinburgh 1994; 987–1015
- Lepercq J, Conrad J, Borel-Derlon A, Darmon J Y, Boudignat O, Francoual C, et al. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. British Journal of Obstetrics and Gynaecology 2001; 108: 1134–1140
- Nelson-Piercy C. Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis. Bailliere's Clinical Obstetrics and Gynaecology 1997; 11: 489–509
- Nelson-Piercy C, Letsky E A, de Swiet M. Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. American Journal of Obstetrics and Gynecology 1997; 176: 1062–1068
- Pettila V, Leinonen P, Markkola A, Hiilesmaa V, Kaaja R. Postpartum bone mineral density in women treated fro thromboprophylaxis with unfractionated heparin or LMW heparin. Thrombosis and Haemostasis 2002; 87: 182–186
- Royal College of Obstetricians and Gynaecologists (RCOG). Prophylaxis against thromboembolism in gynaecology and obstetrics. Report of a Working Party. RCOG Press, London 1995
- Royal College of Obstetricians and Gynaecologists (RCOG). Why mothers die. The Confidential Enquiries into Maternal Deaths in the United Kingdom 1997 – 1999, J Drife, G Lewis. RCOG Press, London 2001
- Royal College of Obstetricians and Gynaecologists (RCOG). Thromboprophylaxis during pregnancy, labour and after vaginal delivery. Guideline No. 37. RCOG Press, London 2004
- Sanson J J, Lensing A WA, Prins M H, Ginsberg J S, Barkagan Z S, Lavenne-Pardonge E, et al. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thrombosis and Haemostasis 1999; 81: 668–672